To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
The USD 5.8 billion (by 2030) financial opportunity within the oligonucleotide synthesis, modification and purification services market has been analyzed across the following segments:
Type of manufacturing
Custom manufacturing
Large-scale manufacturing
Type of Oligonucleotides manufactured
Antisense Oligonucleotides
miRNAs
shRNAs
siRNAs
Other Oligonucleotides
Scale of operation
Clinical
Commercial
Purpose of production
In-house
Outsourced
Target therapeutic area
Autoimmune Disorders
Cardiovascular Disorders
Genetic Disorders
Infectious Diseases
Metabolic Disorders
Neuromuscular Disorders
Oncological Disorders
Ophthalmic Disorders
Other Therapeutic Areas
Size of manufacturer
Small
Mid-sized
Large
Key Geographical Region
North America
Europe
Asia-Pacific and Rest of the World
The Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030”report features the following companies, which we identified to be key players in this domain:
Agilent Technologies
Ajinomoto Bio-Pharma Services
BioSpring
CordenPharma
Integrated DNA Technologies
Kaneka Eurogentec
LGC Biosearch Technologies
Microsynth
Nitto Denko Avecia
Sigma Aldrich
Thermo Fisher Scientific
Trilink Biotechnologies
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape: Oligonucleotide Manufacturers (Research and Diagnostic Applications)
5. Market Landscape: Oligonucleotide Manufacturers (Therapeutic Applications)
6. Company Competitiveness Analysis: Oligonucleotide Manufacturers (Research and Diagnostic Applications)
7. Company Competitiveness Analysis: Oligonucleotide Manufacturers (Therapeutic Applications)
8. Company Profiles: Oligonucleotide Manufacturers (Research and Diagnostic Applications)
9. Company Profiles: Oligonucleotide Manufacturers (Therapeutic Applications)
10. Partnerships and Collaborations
11. Recent Expansions
12. Clinical Trial Analysis
13. Capacity Analysis
14. Demand Analysis
15. Market Sizing and Opportunity Analysis
16. Swot Analysis
17. Survey Analysis
18. Executive Insights
19. Concluding Remarks
20. Appendix 1: Tabulated Data
21. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]